67 results
8-K
EX-99.1
CPRX
Catalyst Pharmaceuticals Inc
1 Jun 23
Catalyst Pharmaceuticals Reports Positive Momentum in Reaffirms Full Year 2023 Total Revenue Guidance of Between
4:30pm
and assessing Catalyst’s business as well as how we manage our business internally and set operational goals. We believe the benefits from our diversified
8-K
EX-99.1
xof koxepjzg
22 Dec 22
Catalyst Pharmaceuticals to Acquire U.S. Commercial Rights to FYCOMPA® (Perampanel) CIII From Eisai Co., Ltd
4:31pm
8-K
EX-99.1
vu45pt93cid xqdeq
9 Nov 22
Catalyst Pharmaceuticals Reports Record Third Quarter 2022 Financial Results and Provides a Corporate Update
4:32pm
8-K
EX-99.1
2qgf988m2u
16 Mar 21
Catalyst Pharmaceuticals Announces Fourth Quarter and Year-End 2020 Financial Results and Provides Corporate Update
8:11am
8-K
EX-99.1
onmtbfeq
6 Jan 20
Catalyst PharmaceuticalsPre-Announces Estimated Firdapse® Revenues and Provides Updates on Advancement of Clinical Development Programs
8:55am
8-K
EX-99.1
g6bzula5tztiqz79l
12 Nov 19
Catalyst Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Corporate Update
4:45pm